We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 306 results
  1. Population pharmacokinetic modeling and dosing simulation of avalglucosidase alfa for selecting alternative dosing regimen in pediatric patients with late-onset pompe disease

    Avalglucosidase alfa (AVAL) was approved in the United States (2021) for patients with late-onset Pompe disease (LOPD), aged ≥ 1 year. In the present...

    Gilles Tiraboschi, David Marchionni, ... Fabrice Hurbin in Journal of Pharmacokinetics and Pharmacodynamics
    Article Open access 03 August 2023
  2. Current trends and future directions for the synthesis and pharmacological applications of 2-(2-cyanopyrrolidin-1-yl)-N-3-hydroxyadamantan-1-yl) acetamide (Gliptins)

    Dipeptidyl peptidase 4 (DPP-4), well known as the T-cell antigen CD26 enzyme which, was discovered in the year of 1966 by Hopsu-Havu and Glenner. The...

    Shaikh Yahya, Mohammad Usman Shaikh, ... M. Shahar Yar in Medicinal Chemistry Research
    Article 11 June 2024
  3. Population pharmacokinetics of primaquine and its metabolites in African males

    Background

    Primaquine (PQ) is the prototype 8-aminoquinoline drug, a class which targets gametocytes and hypnozoites. The World Health Organization...

    Palang Chotsiri, Almahamoudou Mahamar, ... Joel Tarning in Malaria Journal
    Article Open access 21 May 2024
  4. R-praziquantel integrated population pharmacokinetics in preschool- and school-aged African children infected with Schistosoma mansoni and S. haematobium and Lao adults infected with Opisthorchis viverrini

    Racemic praziquantel (PZQ) is the standard treatment for schistosomiasis and liver fluke infections (opisthorchiasis and clonorchiasis). The...

    Christine Falcoz, Serge Guzy, ... Jennifer Keiser in Journal of Pharmacokinetics and Pharmacodynamics
    Article 13 January 2022
  5. Facial and body sexual dimorphism are not interconnected in the Maasai

    Background

    In this paper, we investigate facial sexual dimorphism and its’ association with body dimorphism in Maasai, the traditional seminomadic...

    Marina L. Butovskaya, Victoria V. Rostovtseva, Anna A. Mezentseva in Journal of Physiological Anthropology
    Article Open access 07 January 2022
  6. Pharmacokinetics of PEGasparaginase in Infants with Acute Lymphoblastic Leukemia

    Background

    PEGasparaginase is known to be a critical drug for treating pediatric acute lymphoblastic leukemia (ALL), however, there is insufficient...

    Leiah J. Brigitha, Veerle Mondelaers, ... Inge M. van der Sluis in Pharmaceutical Research
    Article 27 March 2024
  7. The allometry of cellular DNA and ribosomal gene content among microbes and its use for the assessment of microbiome community structure

    Background

    The determination of taxon-specific composition of microbiomes by combining high-throughput sequencing of ribosomal genes with...

    Luis Gonzalez-de-Salceda, Ferran Garcia-Pichel in Microbiome
    Article Open access 17 August 2021
  8. Relationship between body size and sexual size dimorphism in syringophilid quill mites

    A positive relationship of body size and sexual size dimorphism (males’ size relative to females), called Rensch’s rule, is often observed in...

    Lajos Rózsa, Evelyn Moldovan in Parasitology Research
    Article Open access 24 January 2022
  9. A Population Pharmacokinetic Modelling Approach to Unravel the Complex Pharmacokinetics of Vincristine in Children

    Background

    Vincristine, a chemotherapeutic agent that extensively binds to β-tubulin, is commonly dosed at 1.4–2.0 mg/m 2 capped at 2 mg. For infants,...

    A. Laura Nijstad, Wan-Yu Chu, ... Alwin D. R. Huitema in Pharmaceutical Research
    Article Open access 19 August 2022
  10. Unveiling the neuroanatomy of Josephoartigasia monesi and the evolution of encephalization in caviomorph rodents

    Caviomorph rodents are an exceptional model for studying the effects of ecological factors and size relations on brain evolution. These mammals are...

    José Darival Ferreira, Andrés Rinderknecht, ... Leonardo Kerber in Brain Structure and Function
    Article 19 March 2024
  11. Population pharmacokinetics of cyclosporine A in pediatric patients with thalassemia undergoing allogeneic hematopoietic stem cell transplantation

    Purpose

    To establish the population pharmacokinetics (PPK) model of cyclosporine A(CsA) in pediatric patients with thalassemia undergoing allogeneic...

    Rongda Cai, Limin Zhang, ... Taotao Liu in European Journal of Clinical Pharmacology
    Article 08 February 2024
  12. When will the Glomerular Filtration Rate in Former Preterm Neonates Catch up with Their Term Peers?

    Aims

    Whether and when glomerular filtration rate (GFR) in preterms catches up with term peers is unknown. This study aims to develop a GFR maturation...

    Yunjiao Wu, Karel Allegaert, ... Swantje Völler in Pharmaceutical Research
    Article Open access 12 March 2024
  13. Preclinical Pharmacokinetic and Pharmacodynamic Investigation of 5’-Methoxynobiletin from Ageratum conyzoides: In vivo and In silico Approaches

    Purpose

    5’-methoxynobiletin (5’-MeONB), a polymethoxyflavone isolated from A. conyzoides , has shown anti-inflammatory property. Nevertheless, the...

    Larissa Gabriela Faqueti, Layzon Antonio Lemos da Silva, ... Maique Weber Biavatti in Pharmaceutical Research
    Article 13 July 2022
  14. The Development of Aerobic and Anaerobic Fitness with Reference to Youth Athletes

    Purpose

    To challenge current conventions in paediatric sport science and use data from recent longitudinal studies to elucidate the development of...

    Neil Armstrong, Jo Welsman in Journal of Science in Sport and Exercise
    Article Open access 14 August 2020
  15. Monoclonal Antibodies: From Structure to Therapeutic Application

    The exciting field of therapeutic monoclonal antibodies (mAbs) had its origins when Köhler and Milstein presented their murine hybridoma technology...
    Rong Deng, Junyi Li, ... Chunze Li in Pharmaceutical Biotechnology
    Chapter 2024
  16. Population Pharmacokinetic Modeling of Lucitanib in Patients with Advanced Cancer

    Background

    Lucitanib is an oral, potent, selective inhibitor of the tyrosine kinase activity of vascular endothelial growth factor receptors 1‒3,...

    Mingxiang Liao, Jie Zhou, ... Jim **ao in European Journal of Drug Metabolism and Pharmacokinetics
    Article Open access 18 July 2022
  17. Population Pharmacokinetic Modeling and Dose Optimization of Acetaminophen and its Metabolites Following Intravenous Infusion in Critically ill Adults

    Background and Objective

    Acetaminophen (paracetamol) is a ubiquitously administered drug in critically ill patients. Considering the dearth of...

    Kannan Sridharan, Mwila Mulubwa, Ali Mohamed Qader in European Journal of Drug Metabolism and Pharmacokinetics
    Article 30 June 2023
  18. Physiologically Based Pharmacokinetic (PBPK) Modeling: Applications in Drug Development

    Manuel Ibarra, Alejandra Schiavo, Lawrence J. Lesko in The ADME Encyclopedia
    Reference work entry 2022
  19. Population Pharmacokinetic Modelling of Acetaminophen and Ibuprofen: the Influence of Body Composition, Formulation and Feeding in Healthy Adult Volunteers

    Background and Objective

    Combined acetaminophen and ibuprofen are common antipyretic and analgesic drugs. Formulation and feeding affect drug...

    James D. Morse, Ioana Stanescu, ... Brian J. Anderson in European Journal of Drug Metabolism and Pharmacokinetics
    Article Open access 02 April 2022
Did you find what you were looking for? Share feedback.